Autoimmune Hemolytic Anemia Clinical Trials in Beijing, Beijing Municipality
3 recruitingBeijing, Beijing Municipality, China
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)
Systemic Lupus ErythematosusAutoimmune Hemolytic Anemia, AIHA
Circunited BioPharma (Shenzhen) Co., Ltd.5 enrolled1 locationNCT07629596
Recruiting
Not Applicable
Sirolimus in the Treatment of Refractory/Relapsed wAIHA
Warm Autoimmune Hemolytic Anemia
Peking Union Medical College Hospital22 enrolled1 locationNCT05925023
Recruiting
Phase 2
Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA
Warm Autoimmune Hemolytic Anemia
Chen Miao22 enrolled1 locationNCT05922839